DarioHealth Corp (DRIO)
NASDAQ:DRIO

DarioHealth (DRIO) Income Statement

209 Followers

DarioHealth Income Statement

Last quarter (Q2 2023), DarioHealth's total revenue was $6.15M, a decrease of -0.50% from the same quarter last year. In Q2, DarioHealth's net income was $-16.59M. See DarioHealth’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 19.57M$ 27.66M$ 20.51M$ 7.58M$ 7.56M$ 7.39M
Cost of Revenue
$ 6.68M$ -18.00M$ -12.44M$ 5.06M$ 4.96M$ 5.63M
Gross Profit
$ 2.71M$ 9.65M$ 3.96M$ 2.51M$ 2.60M$ 1.76M
Operating Expense
$ 36.30M$ -66.47M$ -80.46M$ 32.42M$ 20.30M$ 19.45M
Operating Income
$ -70.33M$ -86.11M$ -97.01M$ -29.90M$ -17.70M$ -17.69M
Net Non Operating Interest Income Expense
$ -4.59M$ -5.38M$ -235.00K$ 12.00K$ -11.00K$ -18.00K
Other Income Expense
$ -11.31M$ -27.66M$ -20.51M$ 446.00K$ -20.00K$ -97.00K
Pretax Income
$ -57.66M$ -62.19M$ -76.73M$ -29.45M$ -17.74M$ -17.80M
Tax Provision
$ 3.00K$ 4.00K$ 32.00K$ 0.00--
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -56.62M$ -63.84M$ -78.77M$ -33.10M$ -20.89M$ -18.30M
Basic EPS
$ 0.81$ 2.54$ 4.07$ -4.01$ -8.00$ -15.63
Diluted EPS
$ 0.81$ 2.54$ 4.07$ -4.01$ -8.00$ -15.63
Basic Average Shares
$ 102.36M$ 23.64M$ 16.59M$ 5.96M$ 2.27M$ 1.17M
Diluted Average Shares
$ 102.36M$ 23.64M$ 16.59M$ 5.96M$ 2.27M$ 1.17M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 42.98M$ -84.47M$ -92.90M$ 37.48M$ 25.26M$ 25.08M
Net Income From Continuing And Discontinued Operation
$ -56.58M$ -63.84M$ -76.76M$ -29.45M$ -17.74M$ -17.80M
Normalized Income
$ -28.73M--$ -29.89M$ -17.72M$ -17.71M
Interest Expense
------
EBIT
$ -55.63M$ -65.94M$ -76.73M$ -29.90M$ -17.70M$ -17.69M
EBITDA
$ -46.67M$ -57.17M$ -72.27M$ -29.71M$ -17.52M$ -17.48M
Currency in USD

DarioHealth Earnings and Revenue History


What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis